These studies reveal PDK1 and ANXA6 as key drivers of radioresistance via PI3K/AKT/mTOR-mediated autophagy and stemness, offering therapeutic targets for HCC and NPC, but their universality and predictive value across different tumor types require further validation. The gene discussed is AKT1; the disease is hepatocellular carcinoma.